dr. reardon on efficacy/safety of immunotherapy combination in glioblastoma
Published 5 years ago • 514 plays • Length 2:09Download video MP4
Download video MP3
Similar videos
-
2:03
dr. david reardon on immunotherapy and rindopepimut in the glioblastoma treatment paradigm
-
2:03
dr. reardon on the immunogenicity of glioblastoma
-
2:01
dr. reardon on nivolumab/ipilimumab in glioblastoma
-
45:30
immunotherapy for brain cancer, with david reardon
-
1:55
asco22: glioblastoma research by david reardon, md | dana-farber cancer institute
-
1:34
dr. reardon on pembrolizumab and bevacizumab for glioblastoma
-
7:14
glioblastoma: the potential role of immunotherapy
-
1:20
dr. reardon on the need for a new standard of care in gbm
-
1:54
david reardon on caring for patients with glioblastoma
-
4:23
challenges with immunotherapy in glioblastoma
-
2:15
dr. reardon on a phase 1/2 trial examining ino-5401 and ino-9012 in glioblastoma
-
59:55
aiming the immune system at brain cancer, with david reardon
-
2:01
the challenges in using immune checkpoint inhibitors to treat patients with glioblastoma
-
1:33
dr. reardon discusses the mechanism of action of rindopepimut for recurrent glioblastoma
-
33:11
brain cancer and immunotherapy with dr. david reardon
-
1:05
dr. reardon on updated data from the phase ii react trial
-
37:38
learn the basics of immunotherapy from david reardon, m.d.
-
17:25
promising clinical trials for glioblastoma - nicholas butowski, m.d.
-
0:40
immunotherapy for glioblastoma